➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: September 28, 2021

DrugPatentWatch Database Preview

Details for Patent: 8,147,852

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,147,852 protect, and when does it expire?

Patent 8,147,852 protects VUSION and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 8,147,852
Title:Modified azole compounds as antifungal and antibacterial agents
Abstract: The present invention relates to the compounds of formula (I), their preparation and use as antifungal and/or antibacterial agents. ##STR00001## where the values for R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and A are as defined herein.
Inventor(s): Borgers; Marcel (Knokke, BE), van Geffen; Maarten (Beerse, BE), Ausma; Jannie (Goirle, NL)
Assignee: Barrier Therapeutics, Inc. (Princeton, NJ)
Application Number:12/108,262
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 8,147,852

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mylan VUSION miconazole nitrate; petrolatum, white; zinc oxide OINTMENT;TOPICAL 021026-001 Feb 16, 2006 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial USE FOR TREATMENT OF DIAPER DERMATITIS COMPLICATED BY CANDIDIASIS ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,147,852

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2008019030 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.